OLADAYO PRATT: Open Payments
NPI 1457848327 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 28 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 4 | $105 |
| Sumitomo Pharma America, Inc. | 5 | $96 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $64 |
| Caris MPI, Inc. | 2 | $48 |
| Astellas Pharma US Inc | 2 | $48 |
| Genmab U.S., Inc. | 2 | $42 |
| Myriad Genetic Laboratories, Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Ethicon US, LLC | 1 | $22 |
Products named: ZURZUVAE, MYFEMBREE, MI CANCER SEEK, Veozah, Tivdak, MYRISK, Mirena, JOURNAVX.
Industry payments across TX — which companies pay providers there.
